 |
인쇄하기
취소
|
NICE Rates Choongwae's Bond as BB+
The National Information & Credit Evaluation Inc. has given a credit rating of BB+ to the corporate bonds of Choongwae Pharma Corp. BB+ in its 36th main evaluation released on July 28.
Prior to this, Choongwae's credit rating was 'BB+' in the 34th regular evaluation for the corporate bonds on June 29.
The NICE assessed this company, saying "Thanks to its successful introduction of larg...
Prior to this, Choongwae's credit rating was 'BB+' in the 34th regular evaluation for the corporate bonds on June 29.
The NICE assessed this company, saying "Thanks to its successful introduction of larg...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.